Schellenberg Wittmer advised SIX Swiss Exchange-listed ams-OSRAM AG on the sale of its Passive Optical Components Assets. Focuslight Technologies Inc., a global provider of high-power diode...
Focuslight Technologies Inc.’s Acquisition Of Passive Optical Components Assets From ams-OSRAM AG
Boehringer Ingelheim’s Acquisition Of Saiba Animal Health AG
Schellenberg Wittmer advised Boerhringer Ingelheim on the deal. Boehringer Ingelheim has acquired Saiba Animal Health AG, a company focused on the development of novel therapeutic medicines...
HOCHDORF’s Sale Of HOCHDORF Swiss Nutrition And Restructuring Proceedings
Schellenberg Wittmer advised HOCHDORF Holding AG on the deal. Schellenberg Wittmer advised SIX Swiss Exchange-listed HOCHDORF Holding AG, a Swiss market leader in milk processing, specialising...
Gilde Healthcare’s Investment in Swiss Dental Solutions
Schellenberg Wittmer advised Gilde Healthcare on the deal. Gilde Healthcare’s Private Equity Fund (Gilde Healthcare), a specialized healthcare investor, completed the acquisition of a majority of the...
Santhera Pharmaceuticals’ License Agreement With Catalyst Pharmaceuticals
Schellenberg Wittmer advises Santhera on license for North America for Vamorolone. Santhera Pharmaceuticals (SIX: SANN) has signed an exclusive license and collaboration agreement for vamorolone in...
Francotyp-Postalia’s Acquisition of Azolver
DLA Piper and Schellenberg Wittmer advised Francotyp-Postalia Holding AG on the deal. Bird & Bird, Selmer and Homburger advised Azolver Holding. Francotyp-Postalia Holding AG (FP) executed...
All for One Group’s Acquisition of ASC Management Consulting AG and Advanced Solutions Consulting GmbH
Schellenberg Wittmer advised the shareholders of ASC. All for One Group SE, a leading group in IT/SAP, strategy and management consulting listed in the Prime Standard...